Richard D. Katz

Chief Financial & Accounting Officer at Allena Pharmaceuticals, Inc.

Richard D. Katz

Richard D. Katz

Chief Financial & Accounting Officer at Allena Pharmaceuticals, Inc.

Overview
Career Highlights

Allena Pharmaceuticals, Inc.
Viamet Pharmaceuticals Corp.
Liquidia Technologies, Inc.

RelSci Relationships

2970

Number of Boards

1

Birthday

1964

Age

57

Relationships
RelSci Relationships are individuals Richard D. Katz likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Development Officer at Viamet Pharmaceuticals Corp.

Relationship likelihood: Strong

Former President, Chief Executive Officer, Director at Innocrin Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Viamet Pharmaceuticals Corp.

Relationship likelihood: Strong

President & Chief Executive Officer at Cidara Therapeutics, Inc.

Relationship likelihood: Strong

Former Group Director at Pfizer Global Research & Development

Relationship likelihood: Strong

President at Antibiotics Working Group

Relationship likelihood: Strong

Senior Vice President & Global Head, Acute Care Business at Theravance Biopharma, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at SCYNEXIS, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Pulmotect, Inc.

Relationship likelihood: Strong

Venture Partner at Pappas Capital LLC

Relationship likelihood: Strong

Paths to Richard D. Katz
Potential Connections via
Relationship Science
You
Richard D. Katz
Chief Financial & Accounting Officer at Allena Pharmaceuticals, Inc.
Education

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Career History
Vice President
Prior

Goldman, Sachs & Co. (GS&Co.), a limited partnership registered as a U.S. broker-dealer and futures commission merchant, together with its consolidated subsidiaries (collectively, the firm), is an indirectly wholly owned subsidiary of The Goldman Sachs Group, Inc. (Group Inc.), a Delaware corporation. The firm is a leading global investment banking, securities and investment management firm that provides a wide range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals.

Chief Financial & Business Officer
2011 - 2016

Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC.

Chief Financial Officer, Executive Vice President-Finance & Corporate Development
Prior

Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC.

Boards & Committees
Member, Board of Directors
Prior - 2018
Transactions
Details Hidden

Liquidia Technologies, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Richard D. Katz. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Richard D. Katz's profile does not indicate a business or promotional relationship of any kind between RelSci and Richard D. Katz.